New hope for Hard-to-Treat prostate cancer: experimental drug combo trial opens
NCT ID NCT06353386
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This clinical trial is testing an experimental drug called opevesostat (MK-5684), either alone or combined with other cancer drugs, in people with a type of advanced prostate cancer that no longer responds to standard hormone therapy. The study involves 220 participants and has two phases: first to find safe doses, then to see if the treatments shrink tumors or lower PSA levels. It is currently recruiting.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Opevesostat (MK-5684), olaparib, docetaxel, cabazitaxel, fludrocortisone acetate, dexamethasone, prednisone
- What this could lead to
- If successful, this could lead to a new treatment option that helps control advanced prostate cancer that has stopped responding to standard hormone therapy.
- What could go wrong
- This is an early-phase trial (Phase 1/2) with only 220 participants, so the treatments may not prove effective or safe in larger groups. Side effects from the drug combinations could be significant.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS, CASTRATION-RESISTANT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Aalborg Universitetshospital, Syd ( Site 0503)
RECRUITINGAalborg, North Denmark, 9000, Denmark
-
Addenbrooke's Hospital ( Site 1902)
RECRUITINGCambridge, Cambridgeshire, CB2 2QQ, United Kingdom
-
Ankara Bilkent Şehir Hastanesi ( Site 1801)
RECRUITINGAnkara, 06800, Turkey (Türkiye)
-
Asan Medical Center-Oncology ( Site 1500)
RECRUITINGSongpagu, Seoul, 05505, South Korea
-
Auckland City Hospital ( Site 1333)
RECRUITINGAuckland, 1023, New Zealand
-
Azienda Ospedaliera Universitaria Integrata Verona - Ospedal-Centro Ricerche Cliniche di Verona ( Site 1100)
RECRUITINGVerona, 37134, Italy
-
Baskent University Dr. Turgut Noyan Research and Training Center-ONCOLOGY ( Site 1802)
RECRUITINGAdana, 01250, Turkey (Türkiye)
-
Bradfordhill ( Site 0300)
RECRUITINGSantiago, Region M. de Santiago, 8420383, Chile
-
CIDO SpA-Oncology ( Site 0302)
ACTIVE_NOT_RECRUITINGTemuco, Biobio, 4810218, Chile
-
Centre Hospitalier de l'Université de Montréal ( Site 0200)
RECRUITINGMontreal, Quebec, H2X 3E4, Canada
-
Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0207)
RECRUITINGQuébec, Quebec, G1J 1Z4, Canada
-
Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 1402)
RECRUITINGBydgoszcz, Kuyavian-Pomeranian Voivodeship, 85-796, Poland
-
Chang Gung Medical Foundation-Linkou Branch-Medical Oncology ( Site 1702)
RECRUITINGTaoyuan, 333, Taiwan
-
Chang Gung Memorial Hospital at Kaohsiung-Oncology and Hematology ( Site 1704)
RECRUITINGKaohsiung Niao Sung Dist, Kaohsiung, 83301, Taiwan
-
Charité Universitaetsmedizin Berlin - Campus Mitte ( Site 0800)
ACTIVE_NOT_RECRUITINGBerlin, 10117, Germany
-
China Medical University Hospital ( Site 1703)
RECRUITINGTaichung, 404332, Taiwan
-
Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia ( Site 0402)
RECRUITINGBogotá, Bogota D.C., 111321, Colombia
-
Clinica Universidad Catolica del Maule-Oncology ( Site 0304)
RECRUITINGTalca, Maule Region, 3465584, Chile
-
Cork University Hospital ( Site 0902)
RECRUITINGCork, T12 DC4A, Ireland
-
Docrates Syöpäsairaala ( Site 0602)
RECRUITINGHelsinki, Uusimaa, 00180, Finland
-
FALP ( Site 0301)
ACTIVE_NOT_RECRUITINGSantiago, Region M. de Santiago, 7500921, Chile
-
FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 0406)
RECRUITINGBogotá, Bogota D.C., 110131, Colombia
-
Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1103)
RECRUITINGMilan, Lombardy, 20133, Italy
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Medical Oncology ( Site 1102)
COMPLETEDRome, Lazio, 00168, Italy
-
Fundación Valle del Lili-Oncology CIC ( Site 0403)
RECRUITINGCali, Valle del Cauca Department, 760032, Colombia
-
Gallipoli Medical Research Ltd-GMRF CTU ( Site 0107)
RECRUITINGGreenslopes, Queensland, 4120, Australia
-
Gustave Roussy ( Site 0701)
RECRUITINGVillejuif, Île-de-France Region, 94805, France
-
Hacettepe Universite Hastaneleri-oncology hospital ( Site 1800)
RECRUITINGAnkara, 06230, Turkey (Türkiye)
-
Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus) ( Site 0604)
RECRUITINGHelsinki, Uusimaa, 00029, Finland
-
Herlev and Gentofte Hospital ( Site 0501)
RECRUITINGCopenhagen, Capital Region, 2730, Denmark
-
Hopitaux Universitaires de Strasbourg ( Site 0700)
RECRUITINGStrasbourg, Bas-Rhin, 67200, France
-
Hospital Clinico San Carlos-Oncology Department ( Site 1604)
RECRUITINGMadrid, 28040, Spain
-
Hospital General Universitario Gregorio Marañón ( Site 1601)
RECRUITINGMadrid, 28007, Spain
-
Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 1602)
RECRUITINGBarcelona, 08035, Spain
-
Hospital Universitario Ramón y Cajal-Medical Oncology ( Site 1600)
RECRUITINGMadrid, Madrid, Comunidad de, 28034, Spain
-
Hôpital Européen Georges Pompidou-Service d'Oncologie Médicale ( Site 0702)
RECRUITINGParis, 75015, France
-
IMAT S.A.S ( Site 0404)
RECRUITINGMontería, Departamento de Córdoba, 230002, Colombia
-
Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest ( Site 0703)
RECRUITINGBordeaux, Aquitaine, 33076, France
-
Institut Català d'Oncologia - L'Hospitalet-Medical Oncology ( Site 1603)
RECRUITINGL'Hospitalet de Llobregat, Barcelona, 08908, Spain
-
Istanbul Universitesi Cerrahpasa-Medical Oncology ( Site 1804)
RECRUITINGIstanbul, 34668, Turkey (Türkiye)
-
Istituto Clinico Humanitas-U.O di Oncologia medica ed Ematologia ( Site 1101)
RECRUITINGRozzano, Milano, 20089, Italy
-
Jewish General Hospital ( Site 0206)
RECRUITINGMontreal, Quebec, H3T 1E2, Canada
-
Kyushu University Hospital ( Site 1204)
RECRUITINGFukuoka, 812-8582, Japan
-
MEDICAL COLLEGE OF WISCONSIN-Cancer Center Clinical Trials Office ( Site 0020)
RECRUITINGMilwaukee, Wisconsin, 53226, United States
-
Macquarie University-MQ Health Clinical Trials Unit ( Site 0108)
RECRUITINGMacquarie University, New South Wales, 2109, Australia
-
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Oddzial Badan Wczesnych Faz ( Site 1400)
RECRUITINGWarsaw, Masovian Voivodeship, 02-781, Poland
-
Peter MacCallum Cancer Centre-Parkville Cancer Clinical Trials Unit (PCCTU) ( Site 0110)
RECRUITINGMelbourne, Victoria, 3000, Australia
-
Pontificia Universidad Catolica de Chile ( Site 0303)
RECRUITINGSantiago, Region M. de Santiago, 832000, Chile
-
Queen Elizabeth Hospital Birmingham ( Site 1903)
RECRUITINGBirmingham, B15 2TH, United Kingdom
-
Rabin Medical Center ( Site 1001)
RECRUITINGPetah Tikva, 4941492, Israel
-
Rambam Health Care Campus-Oncology Division ( Site 1002)
RECRUITINGHaifa, 3109601, Israel
-
Royal Preston Hospital-Lancashire Clinical Research Facility ( Site 1900)
RECRUITINGPreston, Lancashire, PR2 9HT, United Kingdom
-
Rutgers Cancer Institute of New Jersey ( Site 0033)
ACTIVE_NOT_RECRUITINGNew Brunswick, New Jersey, 08903-2681, United States
-
Samsung Medical Center-Division of Hematology/Oncology ( Site 1501)
RECRUITINGSeoul, 06351, South Korea
-
Severance Hospital, Yonsei University Health System-Medical oncology ( Site 1502)
RECRUITINGSeoul, 03722, South Korea
-
Sheba Medical Center ( Site 1000)
RECRUITINGRamat Gan, 5265601, Israel
-
Sociedad De Oncología y Hematología Del Cesar SAS-Oncology ( Site 0400)
RECRUITINGValledupar, Cesar Department, 200001, Colombia
-
St. Vincent's University Hospital ( Site 0901)
RECRUITINGDublin, Dublin, D04 T6F4, Ireland
-
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 1803)
RECRUITINGIstanbul, 34722, Turkey (Türkiye)
-
Taipei Veterans General Hospital ( Site 1701)
RECRUITINGTaipei, 112, Taiwan
-
Tallaght University Hospital ( Site 0900)
RECRUITINGDublin, D24 NR0A, Ireland
-
The Beatson West of Scotland Cancer Centre ( Site 1904)
RECRUITINGGlasgow, Glasgow City, G12 0YN, United Kingdom
-
The Jikei University Hospital ( Site 1202)
COMPLETEDMitato, Tokyo, 105-8471, Japan
-
Toho University Sakura Medical Center ( Site 1201)
RECRUITINGSakura, Chiba, 285-8741, Japan
-
UCLA Hematology/Oncology - Santa Monica ( Site 0044)
RECRUITINGLos Angeles, California, 90404, United States
-
UCSD Moores Cancer Center ( Site 0039)
RECRUITINGLa Jolla, California, 92037, United States
-
Universitaetsklinikum Hamburg-Eppendorf-Onkologisches Zentrum ( Site 0804)
RECRUITINGHamburg, 20246, Germany
-
Universitaetsklinikum Heidelberg ( Site 0805)
RECRUITINGHeidelberg, Baden-Wurttemberg, 69120, Germany
-
Universitaetsklinikum Tuebingen-Urologie ( Site 0801)
RECRUITINGTübingen, Baden-Wurttemberg, 72076, Germany
-
University College London Hospital ( Site 1905)
RECRUITINGLondon, London, City of, NW1 2PG, United Kingdom
-
University Hospitals Cleveland Medical Center ( Site 0043)
RECRUITINGCleveland, Ohio, 44106, United States
-
University of Maryland-Greenebaum Comprehensive Cancer Center ( Site 0049)
ACTIVE_NOT_RECRUITINGBaltimore, Maryland, 21201, United States
-
University of Miami Hospital and Clinics, Sylvester Cancer Center-Cancer Research Services ( Site 0051)
RECRUITINGMiami, Florida, 33136, United States
-
Uniwersyteckie Centrum Kliniczne ( Site 1405)
RECRUITINGGdansk, Pomeranian Voivodeship, 80-952, Poland
-
Vaasan Keskussairaala ( Site 0603)
RECRUITINGVaasa, Pohjanmaa, 65130, Finland
-
Yokohama City University Medical Center ( Site 1203)
RECRUITINGYokohama, Kanagawa, 232-0024, Japan
-
klinikum rechts der isar der technischen universität münchen-Urologische Klinik und Poliklinik ( Site 0802)
RECRUITINGMunich, Bavaria, 81675, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new daily pill slow advanced prostate cancer?
- Radiation plus hormone therapy may slow resistant prostate cancer
- Real-World data may reveal Pluvicto's true impact on advanced prostate cancer survival
- Mapping the next steps: how men with advanced prostate cancer are treated after standard therapies fail
- Massive data dive aims to uncover best prostate cancer treatments in real life
- New pill aims to shrink Hard-to-Treat cancers